137 related articles for article (PubMed ID: 8656610)
1. The effect of lovastatin on [3H]thymidine uptake in HTC-4 and LLC-L1 tumor cells.
Morris TJ; Palm SL; Furcht LT; Buchwald H
J Surg Res; 1996 Mar; 61(2):367-72. PubMed ID: 8656610
[TBL] [Abstract][Full Text] [Related]
2. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.
Keyomarsi K; Sandoval L; Band V; Pardee AB
Cancer Res; 1991 Jul; 51(13):3602-9. PubMed ID: 1711413
[TBL] [Abstract][Full Text] [Related]
3. Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells.
Reedquist KA; Pope TK; Roess DA
Biochem Biophys Res Commun; 1995 Jun; 211(2):665-70. PubMed ID: 7794281
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effects of lovastatin on the proliferation and cell cycle phase of cultured human glomerular mesangial cells in vitro].
Li H; Li XW; Duan L; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):63-6. PubMed ID: 12905842
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
7. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
8. Dinaline inhibits amino acid transport and proliferation of colon carcinoma cells in vitro.
Schaider H; Haberkorn U; Stöhr M; Berger MR
Anticancer Res; 1995; 15(6B):2501-9. PubMed ID: 8669814
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
11. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin.
Sora MK; Kruszewski AA; Stokłosa T; Czyzyk J; Lasek W; Malejczyk J; Jakóbisiak M
Arch Immunol Ther Exp (Warsz); 1994; 42(4):269-74. PubMed ID: 7487365
[TBL] [Abstract][Full Text] [Related]
13. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
14. Periosteum responds to dynamic fluid pressure by proliferating in vitro.
Saris DB; Sanyal A; An KN; Fitzsimmons JS; O'Driscoll SW
J Orthop Res; 1999 Sep; 17(5):668-77. PubMed ID: 10569475
[TBL] [Abstract][Full Text] [Related]
15. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
Delsite R; Djakiew D
J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
[TBL] [Abstract][Full Text] [Related]
16. Effects of lovastatin alone or combined with irradiation on tumor cells in vitro and in vivo.
Gabryś D; Dörfler A; Yaromina A; Hessel F; Krause M; Oertel R; Baumann M
Strahlenther Onkol; 2008 Jan; 184(1):48-53. PubMed ID: 18188523
[TBL] [Abstract][Full Text] [Related]
17. Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis.
Park WH; Lee YY; Kim ES; Seol JG; Jung CW; Lee CC; Kim BK
Anticancer Res; 1999; 19(4B):3133-40. PubMed ID: 10652602
[TBL] [Abstract][Full Text] [Related]
18. A non-characteristic response of L1210 cells to lovastatin.
Engelke KJ; Hacker MP
Biochem Biophys Res Commun; 1994 Aug; 203(1):400-7. PubMed ID: 8074684
[TBL] [Abstract][Full Text] [Related]
19. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
Zhang Q; Pan J; Zheng RL; Wang Q
Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
